loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 125326 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Novartis Pharmaceuticals Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NOVARTIS (2)

    filter

    01 INJECTABLE; INJECTION (1)

    02 SOLUTION;SUBCUTANEOUS (1)

    filter

    01 Blank (2)

    filter

    01 ARZERRA (1)

    02 KESIMPTA (1)

    filter

    01 Blank (2)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OFATUMUMAB

    PDF Supplier PDF
    URL Supplier Web Content
    INJECTABLE; INJEC...
    100MG/5ML
    125326
    ARZERRA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    OFATUMUMAB

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION; SUBCUTAN...
    20MG/0.4ML
    125326
    KESIMPTA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 125326

    Looking for FDA Orange Book APPLICATION 125326 2

    19

    Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is OFATUMUMAB, with a corresponding application number 125326.

    With a dosage strength 100MG/5ML

    Dosage Form Route INJECTABLE; INJECTION

    18

    Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is OFATUMUMAB, with a corresponding application number 125326.

    With a dosage strength 20MG/0.4ML

    Dosage Form Route SOLUTION; SUBCUTANEOUS

    Post Enquiry
    POST ENQUIRY